## Summary

I've completed a comprehensive investigation of the glucose coefficient discrepancy in your Gompertz PH model. Here are the key findings:

**The glucose coefficient issue is NOT due to:**
- ❌ Unit conversion errors (tested multiple conversion factors)
- ❌ Wrong glucose variable (SGP vs G1P both give similar results)
- ❌ Optimization problems (all approaches converge to same result)
- ❌ Nonlinear transforms (Levine uses linear glucose)

**Key insights:**
1. **The discrepancy is systematic** - it affects multiple biomarkers, not just glucose
2. **Sample composition matters** - including non-fasting people improves the coefficient from 62% to 55% off
3. **Optimization is robust** - all methods find the same global minimum (~0.073)

**Most likely explanations:**
- Different mortality file versions (2019 vs 2015)
- Subtle data processing differences we can't replicate
- Implementation differences between R's flexsurvreg and scipy

**Recommendation**: Accept the empirically-derived coefficient (0.073) as it maintains the correct biological direction and is consistently reproducible across different optimization approaches. The discrepancy appears to be a systematic data/methodology difference rather than a fixable technical issue.

All investigation code and detailed findings have been saved to `research_agents/results_agent2_glucose.md`.
**No significant difference**
G1P only improves by 1.9 percentage points (from 62.4% to 60.9% off).

### Hypothesis C: Nonlinear Glucose Transform
**TESTED**: Linear vs log vs sqrt transforms
- Linear: coefficient = 0.073
- Log transform: coefficient = 0.594 (not comparable to Levine's linear coefficient)
- Square root: coefficient = 0.427 (not comparable)

**RESULT**: ❌ **No evidence for nonlinear transforms**
Levine 2018 clearly uses linear glucose in mmol/L based on BioAge package code.

### Hypothesis D: Sample Selection Issues
**TESTED**: Different sample compositions

| Sample Type | n | Deaths | Glucose Coef | % Off |
|-------------|---|--------|--------------|--------|
| Fasting ≥8h only (PA9) | 8,913 | 1,762 | 0.073 | 62.4% |
| Mixed fasting/non-fasting (n≈9,926) | 10,080 | 1,931 | 0.088 | 55.0% |
| No fasting restriction | 14,480 | - | 0.087 | 55.3% |

**RESULT**: ✅ **Partial improvement**
Including non-fasting people improves glucose coefficient from 62% to 55% off, but still far from target.

### Hypothesis E: Optimization Problems
**TESTED**: Multiple optimization approaches
- Different starting points (Levine's values, zero, random)
- Different optimizers (L-BFGS-B, differential evolution)
- Manual glucose rescaling

**RESULT**: ❌ **Optimization is not the issue**
All approaches converge to the same glucose coefficient (0.073±0.0002), confirming a global minimum.

## Data Quality Analysis

### Glucose Distribution (Fasting ≥8h sample)
```
Mean:   5.44 mmol/L (97.7 mg/dL)
Std:    1.44 mmol/L (25.9 mg/dL)  
Range:  2.78-16.71 mmol/L (50-301 mg/dL)
n:      8,913 people
```

### SGP vs G1P Comparison
```
SGP (serum):         97.7 ± 29.7 mg/dL
G1P (fasting plasma): 101.2 ± 31.4 mg/dL
Correlation:         0.982
```
Both variables are highly correlated and give similar results.

## Key Insights

1. **The issue is not technical**: All conversion factors, optimizers, and glucose variables yield consistent results.

2. **Sample composition matters**: Including non-fasting people improves the coefficient (from 62% to 55% off), suggesting glucose's association with mortality varies by fasting status.

3. **Consistent optimization**: All approaches find the same minimum, ruling out local optima issues.

4. **Other coefficients also differ**: This is not glucose-specific - albumin (52% off), lymphocyte% (68% off), and other biomarkers show similar discrepancies.

## Probable Explanations

The 62% glucose coefficient discrepancy likely stems from:

1. **Different mortality file versions**: We use 2019 mortality data; Levine 2018 used 2015 data (though capped at 240 months).

2. **Subtle data processing differences**: Unknown preprocessing steps in the original analysis that we cannot replicate.

3. **Different sample filtering**: The exact filters to achieve n=9,926 may not be perfectly replicable from available documentation.

4. **Flexsurvreg implementation differences**: The R flexsurvreg package may have different numerical behavior than our scipy implementation.

## Recommendations

1. **Accept the discrepancy**: Our glucose coefficient (0.073) is still biologically plausible and maintains the positive association with mortality.

2. **Focus on relative effects**: The direction and relative magnitude of glucose effects are preserved.

3. **Use our empirically derived coefficients**: Rather than forcing Levine's values, use coefficients fitted on our actual data.

4. **Investigate other biomarkers**: The discrepancy affects multiple biomarkers, suggesting a systematic rather than glucose-specific issue.

## Files Generated
- `investigate_glucose.py`: Initial hypothesis testing
- `investigate_glucose_detailed.py`: Detailed sample selection analysis  
- `investigate_optimization.py`: Optimization robustness testing
- `research_agents/results_agent2_glucose.md`: This summary report
